Comparative aspects of endogenous morphine synthesis and signaling in animals

Annals of the New York Academy of Sciences

Volumn 1163, Issue , 2009, Pages 330-339

  Zhu, Wei ^a   Stefano, George B ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Endogenous morphine; Nitric oxide; opiate receptor

Indexed keywords

ALKALOID; BENZOMORPHAN; DIHYDROMORPHINE; LEVODOPA; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; NITRIC OXIDE; OPIATE; PHENYLPIPERIDINE; UNCLASSIFIED DRUG;

CANCER CELL; CONFERENCE PAPER; DRUG BINDING; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; HORMONE DETERMINATION; HUMAN; INVERTEBRATE; MOLECULAR CLONING; MORPHOGENESIS; NONHUMAN; PROTEIN BLOOD LEVEL; SIGNAL TRANSDUCTION; VERTEBRATE;

ANIMALIA;

EID: 65449118065     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2008.03623.x     Document Type: Conference Paper

References (93)

1. Gintzler, A.R., A. Levy S. Spector. 1976. Antibodies as a means of isolating and characterizing biologically active substances: presence of a non-peptide morphine-like compound in the central nervous system. Proc. Natl. Acad. Sci. USA 73 : 2132 2136.
2. Goldstein, A., R.W. Barrett, I.F. James, et al. 1985. Morphine and other opiates from beef brain and adrenal. Proc. Natl. Acad. Sci. USA 82 : 5203 5207. (Pubitemid 16242829)
3. Cardinale, G.J., J. Donnerer, A.D. Finck, et al. 1987. Morphine and codeine are endogenous components of human cerebrospinal fluid. Life Sci. 40 : 301 306. (Pubitemid 17219695)
4. Donnerer, J., G. Cardinale, J. Coffey, et al. 1987. Chemical characterization and regulation of endogenous morphine and codeine in the rat. J. Pharmacol. Exp. Ther. 242 : 583 587. (Pubitemid 17143493)
5. Donnerer, J., K. Oka, A. Brossi, et al. 1986. Presence and formation of codeine and morphine in the rat. Proc. Natl. Acad. Sci. USA 83 : 4566 4567. (Pubitemid 16057090)
6. Oka, K., J.D. Kantrowitz S. Spector. 1985. Isolation of morphine from toad skin. Proc. Natl. Acad. Sci. USA 82 : 1852 1854. (Pubitemid 15085276)
7. Stefano, G.B. B. Scharrer. 1994. Endogenous morphine and related opiates, a new class of chemical messengers. Adv. Neuroimmunol. 4 : 57 68. (Pubitemid 24238988)
8. Zhu, W., Y. Ma, A. Bell, et al. 2004. Presence of morphine in rat amygdala: evidence for the mu3 opiate receptor subtype via nitric oxide release in limbic structures. Med. Sci. Monit. 10 : BR433 BR439. (Pubitemid 40268549)
9. Goumon, Y. G.B. Stefano. 2000. Identification of morphine in the rat adrenal gland. Mol. Brain Res. 77 : 267 269. (Pubitemid 30317353)
10. Liu, Y., T.V. Bilfinger G.B. Stefano. 1996. A rapid and sensitive quantitation method of endogenous morphine in human plasma. Life Sci. 60 : 237 243.
11. Stefano, G.B., Y. Goumon, F. Casares, et al. 2000. Endogenous morphine. Trends Neurosci. 9 : 436 442. (Pubitemid 26003792)
12. Fricchione, G., W. Zhu, P. Cadet, et al. 2008. Identification of endogenous morphine and a mu opiate alkaloid receptor in human brain tissue taken from a patient with intractable complex partial epilepsy. Med. Sci. Monit. 14 : CS45 CS49.
13. Epple, A., B. Nibbio, S. Spector J. Brinn. 1994. Endogenous codeine: autocrine regulator of catecholamine release from chromaffin cells. Life Sci. 54 : 695 702. (Pubitemid 24095581)
14. Lee, C.S. S. Spector. 1991. Changes of endogenous morphine and codeine contents in the fasting rat. J. Pharmacol. Exp. Ther. 257 : 647 650.
15. Zhu, W., Y. Ma, P. Cadet, et al. 2003. Presence of reticuline in rat brain: a pathway for morphine biosynthesis. Mol. Brain Res. 117 : 83 90. (Pubitemid 37123113)
16. Brix-Christensen, V., E. Tonnesen, R.G. Sanchez, et al. 1997. Endogenous morphine levels increase following cardiac surgery as part of the antiinflammatory response? Int. J. Cardiol. 62 : 191 197. (Pubitemid 28060149)
17. Cadet, P., W. Zhu, K. Mantione, et al. 2003. Cyclic exercise induces anti-inflammatory signal molecule increases in the plasma of Parkinson's patients. Int. J. Mol. Med. 12 : 485 492.
18. Stefano, G.B., W. Zhu, P. Cadet, et al. 2002. A hormonal role for endogenous opiate alkaloids: vascular tissues. Neuroendocrinol. Lett. 23 : 21 26. (Pubitemid 34192865)
19. Stefano, G.B., W. Zhu, P. Cadet K. Mantione. 2004. Morphine enhances nitric oxide release in the mammalian gastrointestinal tract via the μ3 opiate receptor subtype: a hormonal role for endogenous morphine. J. Physiol. Pharmacol. 55 : 279 288. (Pubitemid 38450992)
20. Zhu, W., P. Cadet, G. Baggerman, et al. 2005. Human white blood cells synthesize morphine: CYP2D6 modulation. J. Immunol. 175 : 7357 7362. (Pubitemid 41713432)
21. Stefano, G.B., A. Digenis, S. Spector, et al. 1993. Opiate-like substances in an invertebrate, an opiate receptor on invertebrate and human immunocytes, and a role in immunosuppression. Proc. Natl. Acad. Sci. USA 90 : 11099 11103. (Pubitemid 23354376)
22. Goumon, Y., F. Casares, W. Zhu G.B. Stefano. 2001. The presence of morphine in ganglionic tissues of Modiolus deminissus: a highly sensitive method of quantitation for morphine and its derivatives. Mol. Brain Res. 86 : 184 188. (Pubitemid 32124772)
23. Zhu, W., Y. Ma G.B. Stefano. 2002. Presence of isoquinoline alkaloids in molluscan ganglia. Neuroendocrinol. Lett. 23 : 329 334. (Pubitemid 37281149)
24. Zhu, W., G. Baggerman, Y. Goumon, et al. 2001. Presence of morphine and morphine-6-glucuronide in the marine mollusk Mytilus edulis ganglia determined by GC/MS and Q-TOF-MS. Starvation increases opiate alkaloid levels. Brain Res. Mol. Brain Res. 88 : 155 160. (Pubitemid 32274269)
25. Stefano, G.B., E. Bianchi, M. Guarna, et al. 2007. Nicotine, alcohol and cocaine coupling to reward processes via endogenous morphine signaling: the dopamine-morphine hypothesis. Med. Sci. Monit. 13 : RA91 102. (Pubitemid 46860293)
26. Stefano, G.B. R. Kream. 2008. Endogenous opiates, opioids, and immune function: evolutionary brokerage of defensive behaviors. Semin. Cancer Biol. 18 : 190 198.
27. Stefano, G.B., R.M. Kream, K.J. Mantione, et al. 2008. Endogenous morphine/nitric oxide-coupled regulation of cellular physiology and gene expression: implications for cancer biology. Semin. Cancer Biol. 18 : 199 210.
28. Esch, T., J.W. Kim G.B. Stefano. 2006. Neurobiological implications of eating healthy. Neuro. Endocrinol. Lett. 27: 21-33.
29. Stefano, G.B., G.L. Fricchione T. Esch. 2006. Relaxation: molecular and physiological significance. Med. Sci. Monit. 12 : HY21 31. (Pubitemid 44371892)
30. Casares, F.M., A. McElroy, K.J. Mantione, et al. 2005. The American lobster, Homarus americanus, contains morphine that is coupled to nitric oxide release in its nervous and immune tissues: evidence for neurotransmitter and hormonal signaling. Neuroendocrinol. Lett. 26 : 89 97. (Pubitemid 40674209)
31. Stefano, G.B., A. Hartman, T.V. Bilfinger, et al. 1995. Presence of the mu3 opiate receptor in endothelial cells: coupling to nitric oxide production and vasodilation. J. Biol. Chem. 270 : 30290 30293. (Pubitemid 3022823)
32. Cadet, P., K.J. Mantione G.B. Stefano. 2003. Molecular identification and functional expression of mu3, a novel alternatively spliced variant of the human mu opiate receptor gene. J. Immunol. 170 : 5118 5123. (Pubitemid 36554743)
33. Goumon, Y., F. Casares, S. Pryor, et al. 2000. Ascaris suum, an internal parasite, produces morphine. J. Immunol. 165 : 339 343. (Pubitemid 30429525)
34. Zhu, W., S.C. Pryor, J. Putnam, et al. 2004. Opiate alkaloids and nitric oxide production in the nematode Ascaris suum. J. Parasitol. 90 : 15 22. (Pubitemid 38280723)
35. Zhu, W., G. Baggerman, W.E. Secor, et al. 2002. Dracunculus medinensis and Schistosoma mansoni contain opiate alkaloids. Ann. Trop. Med. Parasitol. 96 : 309 316. (Pubitemid 34548051)
36. Goumon, Y., B.S. Weeks, P. Cadet G.B. Stefano. 2000. Identification of morphine in the adrenal medullary chromaffin PC-12 cell line. Mol. Brain Res. 81 : 177 180.
37. Zhu, W., G. Baggerman, Y. Goumon, et al. 2001. Identification of morphine and morphine-6-glucuronide in the adrenal medullary chromaffin PC-12 cell line by nano electrospray ionization double quadrupole orthogonal acceleration time of flight mass spectrometry. Eur. J. Mass. Spect. 7 : 25 28. (Pubitemid 33676294)
38. Muller, A., E. Glattard, O. Taleb, et al. 2008. Endogenous morphine in SH-SY5Y cells and the mouse cerebellum. PloS ONE 3 (2). Epub : http://www.plosone.org/doi/pone.0001641.
39. Poeaknapo, C., J. Schmidt, M. Brandsch, et al. 2004. Endogenous formation of morphine in human cells. Proc. Natl. Acad. Sci. USA 101 : 14091 14096. (Pubitemid 39305035)
40. Olsen, P., M. Rasmussen, W. Zhu, et al. 2005. Human gliomas contain morphine. Med. Sci. Monit. 11 : MS18 MS21. (Pubitemid 40790945)
41. Rasmussen, M., W. Zhu, J. Tonnesen, et al. 2002. Effects of morphine on tumour growth. Neuroendocrinol. Lett. 23 : 193 198. (Pubitemid 34741926)
42. Cadet, P., M. Rasmussen, W. Zhu, et al. 2004. Endogenous morphinergic signaling and tumor growth. Front. Biosci. 9 : 3176 3186.
43. Zhu, W., K.J. Mantione, L. Shen, et al. 2005. Tyrosine and tyramine increase endogenous ganglionic morphine and dopamine levels in vitro and in vivo: CYP2D6 and tyrosine hydroxylase modulation demonstrates a dopamine coupling. Med. Sci. Monit. 11 : BR397 BR404. (Pubitemid 41695480)
44. Zhu, W., K.J. Mantione, L. Shen G.B. Stefano. 2005. In vivo and in vitro L-DOPA exposure increases ganglionic morphine levels. Med. Sci. Monit. 11 : MS1 MS5. (Pubitemid 40790943)
45. Poeaknapo, C., J. Schmidt, M. Brandsch, et al. 2004. Endogenous formation of morphine in human cells. Proc. Natl. Acad. Sci. USA 101 : 14091 14096. (Pubitemid 39305035)
46. Boettcher, C., M. Fellermeier, C. Boettcher, et al. 2005. How human neuroblastoma cells make morphine. Proc. Natl. Acad. Sci. USA 102 : 8495 8500. (Pubitemid 40862764)
47. Kream, R.M. G.B. Stefano. 2006. De novo biosynthesis of morphine in animal cells: an evidence-based model. Med. Sci. Monit. 12 : RA207 RA219. (Pubitemid 44556096)
48. Hiroi, T., S. Imaoka Y. Funae. 1998. Dopamine formation from tyramine by CYP2D6. Biochem. Biophys. Res. Commun. 249 : 838 843. (Pubitemid 28441925)
49. Miller, G.P., I.H. Hanna, Y. Nishimura F.P. Guengerich. 2001. Oxidation of phenethylamine derivatives by cytochrome P450 2D6: the issue of substrate protonation in binding and catalysis. Biochemistry 40 : 14215 14223. (Pubitemid 33081625)
50. Guengerich, F.P., G.P. Miller, I.H. Hanna, et al. 2002. Oxidation of methoxyphenethylamines by cytochrome P450 2D6. Analysis of rate-limiting steps. J. Biol. Chem. 277 : 33711 33719.
51. Niwa, T., T. Hiroi, D. Tsuzuki, et al. 2004. Effect of genetic polymorphism on the metabolism of endogenous neuroactive substances, progesterone and p-tyramine, catalyzed by CYP2D6. Brain Res Mol. Brain Res. 129 : 117 123. (Pubitemid 39304255)
52. Stefano, G.B. R.M. Kream. 2007. Endogenous morphine synthetic pathway preceded and gave rise to catecholamine synthesis in evolution (review). Int. J. Mol. Med. 20 : 837 841.
53. Lord, J.A.H., A.A. Waterfield, J. Hughes H.W. Kosterlitz. 1977. Endogenous opioid peptodes: multiple agonists and receptors. Nature 267 : 495 499. (Pubitemid 8098466)
54. Clark, J.A., L. Liu, M. Price, et al. 1989. Kappa opiate receptor multiplicity: evidence for two U50, 488- sensitive K1 subtypes and a novel K3 subtype. J. Pharmacol. Exp. Ther. 251 : 461 468.
55. Rothman, R.B., V. Bykov, B.R. DeCosta, et al. 1990. Interaction of endogenous opioid peptides and other drugs with four kappa binding sites in guinea pig brain. Peptides 11 : 311 331. (Pubitemid 20144902)
56. Stefano, G.B., P. Melchiorri, L. Negri, et al. 1992. (D-Ala2)-Deltorphin I binding and pharmacological evidence for a special subtype of delta opioid receptor on human and invertebrate immune cells. Proc. Natl. Acad. Sci. USA 89 : 9316 9320.
57. Traynor, J.R. J. Elliott. 1993. δ-Opioid receptor subtypes and cross-talk with mu-receptors. Trends. Pharmacol. Sci. 14 : 84 86. (Pubitemid 23096438)
58. Pasternak, G.W. 1988. The Opiate Receptors. Humana Press. Clifton, NJ.
59. Wolozin, B.L. G.W. Pasternak. 1981. Classification of multiple morphine and enkephalin binding sites in the central nervous system. Proc. Natl. Acad. Sci. USA 78 : 6181 6185. (Pubitemid 12174847)
60. Lutz, R.A., R.A. Cruciani, T. Costa, et al. 1984. A very high affinity opioid binding site in a rat brain: demonstration by computer modeling. Biochem. Biophys. Res. Commun. 122 : 265 269. (Pubitemid 14094533)
61. Cadet, P., K.J. Mantione, W. Zhu, et al. 2007. A functionally coupled mu3-like opiate receptor/nitric oxide regulatory pathway in human multi-lineage progenitor cells. J. Immunol. 179 : 5839 5844.
62. Cruciani, R.A., B. Dvorkin, H.P. Klinger M.H. Makman. 1994. Presence in neuroblastoma cells of a μ3 receptor with selectivity for opiate alkaloids but without affinity for opioid peptides. Brain Res. 667 : 229 237.
63. Makman, M.H., T.V. Bilfinger G.B. Stefano. 1995. Human granulocytes contain an opiate receptor mediating inhibition of cytokine-induced activation and chemotaxis. J. Immunol. 154 : 1323 1330.
64. Makman, M.H., B. Dvorkin G.B. Stefano. 1995. Murine macrophage cell lines contain μ3-opiate receptors. Eur. J. Pharmacol. 273 : R5 R6.
65. 3 opiate receptor subtype. Acta Pharmacol. Sin. 19 : 403 407.
66. Stefano, G.B. 1999. The μ3 opiate receptor subtype. Pain Forum. 8 : 206 209.
67. Ferreira, S.H., I.D. Duarte B.B. Lorenzetti. 1991. The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide release. Eur. J. Pharmacol. 201 : 121.
68. Przewlocki, R., H. Machelska B. Przewlocka. 1993. Inhibition of nitric oxide synthase enhances morphine antinociception in the rat spinal cord. Life Sci. 53 : PL1 5. (Pubitemid 23161508)
69. Majeed, N.H., B. Przewlocka, H. Machelska R. Przewlocki. 1994. Inhibition of nitric oxide synthase attenuates the development of morphine tolerance and dependence in mice. Neuropharmacology 33 : 189 192. (Pubitemid 24104280)
70. Fecho, K., K.A. Maslonek, M.E. Coussons-Read, et al. 1994. Macrophage-derived nitric oxide is involved in the depressed concanavalin A responsiveness of splenic lymphocytes from rats administered morphine in vivo. J. Immunol. 152 : 5845 5851. (Pubitemid 24174164)
71. Gyires, K. 1994. The role of endogenous nitric oxide in the gastroprotective action of morphine. Eur. J. Pharmacol. 255 : 33 37. (Pubitemid 24105741)
72. Magazine, H.I., Y. Liu, T.V. Bilfinger, et al. 1996. Morphine-induced conformational changes in human monocytes,granulocytes, and endothelial cells and in invertebrate immunocytes and microglia are mediated by nitric oxide. J. Immunol. 156 : 4845 4850. (Pubitemid 26174471)
73. Stefano, G.B., B. Scharrer, E.M. Smith, et al. 1996. Opioid and opiate immunoregulatory processes. Crit. Rev. Immunol. 16 : 109 144. (Pubitemid 26303717)
74. Bilfinger, T.V., A. Hartman, Y. Liu, et al. 1997. Cryopreserved veins used for myocardial revascularization: a 5 year experience and a possible mechanism for their increased failure. Ann. Thorac. Surg. 63 : 1063 1069. (Pubitemid 27191661)
75. Sawada, M., M. Ichinose G.B. Stefano. 1997. Nitric oxide inhibits the dopamine-induced K+ current via guanylate cyclase in Aplysia neurons. J. Neurosci. Res. 50 : 450 456. (Pubitemid 27488324)
76. Stefano, G.B., B. Salzet, C.M. Rialas, et al. 1997. Morphine and anandamide stimulated nitric oxide production inhibits presynaptic dopamine release. Brain Res. 763 : 63 68. (Pubitemid 27323739)
77. Bilfinger, T.V., C. Fimiani G.B. Stefano. 1998. Morphine's immunoregulatory actions are not shared by fentanyl. Int. J. Cardiol. 64 : 61 66. (Pubitemid 28293466)
78. Prevot, V., C. Rialas, D. Croix, et al. 1998. Morphine and anandamide coupling to nitric oxide stimulated GnRH and CRF release from rat median eminence: neurovascular regulation. Brain Res. 790 : 236 244. (Pubitemid 28234508)
79. Stefano, G.B. 1998. Autoimmunovascular regulation: morphine and anandamide stimulated nitric oxide release. J. Neuroimmunol. 83 : 70 76. (Pubitemid 28280953)
80. Stefano, G.B., M. Salzet T.V. Bilfinger. 1998. Long-term exposure of human blood vessels to HIV gp120, morphine and anandamide increases endothelial adhesion of monocytes: uncoupling of nitric oxide. J. Cardiovasc. Pharmacol. 31 : 862 868. (Pubitemid 28265295)
81. Stefano, G.B., M. Salzet, H.I. Magazine T.V. Bilfinger. 1998. Antagonist of LPS and IFN-γ induction of iNOS in human saphenous vein endothelium by morphine and anandamide by nitric oxide inhibition of adenylate cyclase. J. Cardiovasc. Pharmacol. 31 : 813 820. (Pubitemid 28265289)
82. Fimiani, C., D.W. Mattocks, F. Cavani, et al. 1999. Morphine and anandamide stimulate intracellular calcium transients in human arterial endothelial endothelial cells: coupling to nitric oxide release. Cellular Signaling 11 : 189 193. (Pubitemid 29185137)
83. Pryor, S.C., W. Zhu, P. Cadet, et al. 2005. Endogenous morphine: opening new doors for the treatment of pain and addiction. Expert Opin. Biol. Ther. 5 : 893 906. (Pubitemid 41032847)
84. Tubaro, E., G. Borelli, C. Croce, et al. 1983. Effect of morphine on resistance to infection. J. Infect. Dis. 148 : 656 666.
85. Weber, R.J., L.C. Band, B. DeCosta, et al. 1991. Neural control of immune function: opioids, opioid receptors and immunosuppression. NIDA Res. Monogr. 105 : 96 102.
86. Perez-Castrillon, J.P., J.P. Perez-Arellano, J.D. Garcia-Palomo, et al. 1992. Opioids depress in vitro human monocyte chemotaxis. Immunopharmacol. 23 : 57 61.
87. Stefano, G.B. T.V. Bilfinger. 1993. Human neutrophil and macrophage chemokinesis induced by cardiopulmonary bypass: loss of DAME and IL-1 chemotaxis. J. Neuroimmunol. 47 : 189 198. (Pubitemid 23284283)
88. Zhu, W., K.J. Mantione, F.M. Casares, et al. 2006. Alcohol-, nicotine-, and cocaine-evoked release of morphine from invertebrate ganglia: model system for screening drugs of abuse. Med. Sci. Monit. 12 : BR155 BR161.
89. Zhu, W., K.J. Mantione, L. Shen, et al. 2006. Norlaudanosoline and nicotine increase endogenous ganglionic morphine levels: nicotine addiction. Cell Mol. Neurobiol. 26 : 1037 1045.
90. Zhu, W., K.J. Mantione, F.M. Casares, et al. 2006. Cholinergic regulation of endogenous morphine release from lobster nerve cord. Med. Sci. Monit. 12 : BR295 BR301. (Pubitemid 44371879)
91. Zhu, W., K. Mantione, R.M. Kream G.B. Stefano. 2006. Alcohol-, nicotine-, and cocaine-evoked release of morphine from human white blood cells: substances of abuse actions converge on endogenous morphine release. Med. Sci. Monit. 12 : BR350 BR354.
92. Zhu, W., K.J. Mantione, R.M. Kream, et al. 2007. Cholinergic regulation of morphine release from human white blood cells: evidence for a novel nicotinic receptor via pharmacological and microarray analysis. Int. J. Immunopathol. Pharmacol. 20 : 229 237.
93. Zhu, W., T. Esch, R.M. Kream G.B. Stefano. 2008. Converging cellular processes for substances of abuse: endogenous morphine. Neuro. Endocrinol. Lett. 29 : 63 66.